Knowledge and practices regarding infant vaccination: results of a survey of French physicians

Bakhache, P.; Virey, B.; Bienenfeld, Christina

doi:10.1007/s00431-018-03314-3

Cited by 14 publications

(3 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared with vaccines which require reconstitution, fully-liquid vaccines reduce vaccination errors and preparation time, and therefore, provide greater satisfaction among healthcare professionals [47]. For example, a survey of French physicians suggest that vaccine reconstitution is a complicating factor in pediatric immunization and is associated with errors and time loss, although it allows more time to talk to parents or distract the infant [48]. Similarly, German healthcare professionals preferred fully-liquid hexavalent vaccines over those requiring reconstitution because of decreased preparation time and reduced risk of handling and dosage errors [49].…”

Section: Place Of Hexyon® In the Prevention Of Major Childhood Diseasesmentioning

confidence: 99%

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

Syed

2019

Pediatr Drugs

View full text Add to dashboard Cite

Hexyon ® is a fully-liquid, ready-to-use, hexavalent vaccine approved in the EU since 2013 for primary and booster vaccination in infants and toddlers from age 6 weeks against diphtheria, tetanus, pertussis, hepatitis B (HB), poliomyelitis, and invasive diseases caused by Haemophilus influenzae type b (Hib). While the source of HB antigen in Hexyon ® is different from other vaccines, the rest of its valences have been extensively used in other approved vaccines. Hexyon ® is highly immunogenic for all its component toxoids/antigens when used as primary and booster vaccine in infants and toddlers, irrespective of vaccination schedule. It provides durable protection against hepatitis B. Hexyon ® can be used for a mixed primary series of hexavalent-pentavalent-hexavalent vaccines or as a booster in infants primed with Infanrix hexa™ or pentavalent (whole-cell or acellular pertussis) vaccines. Coadministration of Hexyon ® with other common childhood vaccines did not affect immune response to any vaccines. Hexyon ® has a good reactogenicity/safety profile. The immunogenicity and safety profile of Hexyon ® was similar to that of several approved vaccines, including Infanrix hexa™. However, Hexyon ® offers the convenience of full-liquid, ready-to-use formulation, which may minimize vaccination errors and preparation time. Thus, Hexyon ® is a convenient, useful option for vaccination against childhood diseases caused by six major pathogens.

show abstract

Section: Place Of Hexyon® In the Prevention Of Major Childhood Diseasesmentioning

confidence: 99%

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

Syed

2019

Pediatr Drugs

View full text Add to dashboard Cite

show abstract

“…Forty-five studies explored HCPs’ perceptions of vaccine effectiveness. Despite one study reporting that 98–99% of HCPs had confidence in the ability of vaccination to protect against infectious diseases in France , 76 perceived lack of effectiveness was one of the most commonly cited barrier to accepting or recommending vaccination in general among HCPs in many countries, including 17–46% of doctors and nurses in Switzerland , 15 , 69 37.3% of Slovenian HCPs, 77 32.2% of nurses from Ireland , 33 24% of HCPs from Greece , 78 13% of midwives in France , 29 and 7.3%-9% of HCPs in Italy . 39 , 79 , 80 Additionally, when GPs in the UK were asked to select the top three factors that would influence their recommendation of a new vaccine, 45–57% of them reported vaccine effectiveness.…”

Section: Resultsmentioning

confidence: 98%

Factors influencing healthcare professionals’ confidence in vaccination in Europe: a literature review

Pavlovic

Sahoo

Larson

et al. 2022

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Health-care professionals (HCPs) have a fundamental role in vaccination, their own beliefs and attitudes affecting both their uptake and recommendation of vaccines. This literature review (n = 89) summarises evidence on HCPs’ perceptions of the risks and benefits of vaccination, trust, and perceptions of mandatory vaccination in Europe. HCPs across studies believed that vaccination is important to protect themselves and their patients. However, beliefs that some diseases such as influenza are less risky were reported by some HCPs as a reason for not getting vaccinated. Concerns about both short- and long-term side effects were identified among HCPs in most studies, such as those affecting the immune or neurological system. Mistrust toward health authorities and pharmaceutical industry was reported in some studies. The question of mandatory vaccination revealed mixed opinions, with some favoring self-determination and others viewing vaccination as a duty. This review highlights key factors influencing HCPs’ confidence in vaccination in Europe.

show abstract

“…Second, many studies focus on physicians' and nurses knowledge of the procedural aspects of giving vaccinations, such as vaccination timetables ( 20 ), their knowledge of official recommendations ( 21 – 23 ), and on their ability to recommend and convince their patients rather than on the depth of their knowledge. In addition, a large portion of research studies focus on HCWs' viewpoints on vaccinations, particularly those that are the topic of scientific controversy, such as the HPV vaccination ( 24 , 25 ).…”

Section: Introductionmentioning

confidence: 99%

Physicians' Perspective on Vaccine-Hesitancy at the Beginning of Israel's COVID-19 Vaccination Campaign and Public's Perceptions of Physicians' Knowledge When Recommending the Vaccine to Their Patients: A Cross-Sectional Study

Gesser‐Edelsburg

Keywan

2022

Front. Public Health

View full text Add to dashboard Cite

Because public healthcare workers (HCWs) are at the forefront of the battle against COVID-19, they must be able to provide vaccination information to their patients and respond to their anxieties and concerns. This research objectives were to (1) examine physicians' perceptions of how they received information about the Pfizer COVID-19 vaccine, their attitudes toward hesitant colleagues, and their own knowledge and self-efficacy in communicating information to their patients, and (2) to examine the public's perceptions of physicians' knowledge when recommending the COVID-19 vaccine to their patients. At the beginning of the vaccination campaign, a survey examined the attitudes of physicians in the Israeli public healthcare system (n = 295) regarding the Pfizer vaccine. In addition, the attitudes of a representative sample (n = 500) of the Israeli adult population (age 18+) were examined through interviews. Most of the participating physicians (81%) reported they had already been vaccinated or intended to be vaccinated. When asked about their reasons for vaccine hesitancy, 27% cited concerns about long-term side effects and doubts about the vaccine's effectiveness in preventing contagion. They cited system pressure and departmental norms as explanations for their eventual compliance. Moreover, they saw the system as less tolerant of hesitant physicians, while they themselves tend to be more tolerant. The results of the survey of the public showed that mostly young people (under 44) who tend to be critical believe that physicians do not have sufficient knowledge to make recommendations about the COVID-19 vaccine. The findings indicate that the health system should employ complete transparency in conveying the advantages and disadvantages of the COVID-19 vaccine to physicians. The system should be more tolerant of physicians' worries and concerns and grant legitimacy to their reservations and misgivings. Moreover, medical studies should reinforce physicians' immunological knowledge regarding vaccinations so they can help their patients make informed decisions.

show abstract

Knowledge and practices regarding infant vaccination: results of a survey of French physicians

Cited by 14 publications

References 12 publications

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

Factors influencing healthcare professionals’ confidence in vaccination in Europe: a literature review

Physicians' Perspective on Vaccine-Hesitancy at the Beginning of Israel's COVID-19 Vaccination Campaign and Public's Perceptions of Physicians' Knowledge When Recommending the Vaccine to Their Patients: A Cross-Sectional Study

Contact Info

Product

Resources

About